Viewing Study NCT06514794


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-25 @ 7:27 PM
Study NCT ID: NCT06514794
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-07-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Sponsor: Wugen, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T-cell Acute Lymphoblastic Leukemia View
None Lymphoblastic Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR-T Therapy View